| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |